Bicocca Open Archive

Logo unimib boa
CIACCIO, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.753
EU - Europa 2.677
AS - Asia 1.152
SA - Sud America 123
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 6
Totale 8.747
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.666
IT - Italia 618
DE - Germania 466
SG - Singapore 461
RU - Federazione Russa 393
CN - Cina 352
SE - Svezia 332
IE - Irlanda 266
UA - Ucraina 176
HK - Hong Kong 132
GB - Regno Unito 125
BR - Brasile 97
CA - Canada 84
IN - India 62
AT - Austria 60
DK - Danimarca 56
FI - Finlandia 53
FR - Francia 43
VN - Vietnam 38
NL - Olanda 25
BE - Belgio 24
TR - Turchia 22
KR - Corea 16
ID - Indonesia 12
EU - Europa 10
IR - Iran 10
EC - Ecuador 9
ES - Italia 8
TW - Taiwan 8
ET - Etiopia 7
DZ - Algeria 6
AR - Argentina 5
CZ - Repubblica Ceca 5
MY - Malesia 5
AU - Australia 4
BD - Bangladesh 4
JP - Giappone 4
MM - Myanmar 4
PL - Polonia 4
VE - Venezuela 4
ZA - Sudafrica 4
BG - Bulgaria 3
CH - Svizzera 3
CL - Cile 3
CO - Colombia 3
IQ - Iraq 3
JO - Giordania 3
MD - Moldavia 3
MX - Messico 3
NO - Norvegia 3
OM - Oman 3
PH - Filippine 3
TH - Thailandia 3
EG - Egitto 2
HU - Ungheria 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
UZ - Uzbekistan 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
GA - Gabon 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
KE - Kenya 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LT - Lituania 1
MA - Marocco 1
ME - Montenegro 1
RO - Romania 1
SC - Seychelles 1
SN - Senegal 1
TJ - Tagikistan 1
UY - Uruguay 1
Totale 8.747
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.025
Woodbridge 448
Fairfield 350
Chandler 311
Singapore 309
Houston 304
Frankfurt am Main 277
Dublin 258
Ashburn 234
Wilmington 217
Jacksonville 177
Milan 162
Dearborn 154
New York 135
Hong Kong 132
Cambridge 127
Seattle 125
Princeton 104
Santa Clara 92
Nanjing 65
Shanghai 57
Vienna 54
Altamura 53
Lawrence 47
Lachine 31
Beijing 26
Dong Ket 26
Lissone 24
San Diego 23
Council Bluffs 22
Guangzhou 20
Los Angeles 20
Moscow 20
Shenyang 20
Helsinki 18
Nanchang 18
Brussels 17
Ottawa 17
Fremont 16
London 16
Tianjin 16
Andover 15
Pune 15
Toronto 14
Boston 13
Jiaxing 13
Rome 13
Jinan 12
Boardman 11
Jakarta 11
Hebei 10
Nürnberg 10
Zhengzhou 10
Changsha 9
Hangzhou 9
Kunming 9
Mountain View 9
Ningbo 9
Nuremberg 9
Bologna 8
Edmonton 8
Bergamo 7
Chicago 7
Montréal 7
Valencia 7
Busto Arsizio 6
Dallas 6
Garbagnate Milanese 6
Legnano 6
Manchester 6
Norwalk 6
Quito 6
Sacramento 6
Taizhou 6
Falls Church 5
Floridia 5
Foggia 5
Valmadrera 5
Bonndorf 4
Comazzo 4
Delhi 4
Desio 4
Dhaka 4
Hanover 4
Indianapolis 4
Kuala Lumpur 4
Monza 4
Nottingham 4
Nutley 4
Padova 4
San Francisco 4
Seoul 4
São Paulo 4
Taipei 4
Torino 4
Verona 4
Vigevano 4
Washington 4
Aachen 3
Bangkok 3
Totale 5.972
Salva come PNG Salva come JPEG
Nome #
Impact of multidisciplinary team approach to liver tumors: 5-Years experience 394
Impact of multidisciplinary team approach to liver tumors in a tertiary center: 5-years experience 365
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 318
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 260
Trattamento con Sofosbuvir e Ribavirina nei pazienti hcv-positivi listati per il trapianto di fegato: un analisi di costo-efficacia 232
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 215
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 210
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 207
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 207
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 206
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 197
Health Related Quality of Life in the Major Liver Conditions 196
Health related quality of life in chronic liver diseases 196
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 195
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 193
The impact of liver disease on the health-related quality of life 192
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 189
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 188
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 187
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 185
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 184
Should new antiviral treatments be considered in elderly Chronic Hepatitis C patients? 182
Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients? 179
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 178
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 178
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 177
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 174
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 173
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 172
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 169
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 166
The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation 163
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 161
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 158
Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis 153
Management of Chronic hepatitis C (CHC) Genotype 1 treatment-naive patients in an era of rising opportunities and costs - A cost-effectiveness analysis of treatment options 151
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 150
Cost-effectiveness of Sofosbuvir plus Ledipasvir Antiviral Treatment for Elderly Patients with Chronic Hepatitis C Genotype 1 146
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 141
Systematic review: economic evaluations of HCV screening in the direct-acting antivirals era 126
Difference in health related quality of life of chronic liver diseases and general population 125
Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured? 121
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 121
Sofosbuvir and ribavirinin in HCV-infected patients listed for liver transplantation: A cost-effectiveness analysis 120
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 119
Cost-effectiveness of new direct-acting antivirals to prevent post-liver transplant recurrent hepatitis 116
Hepatitis C virus infection and diabetes: a complex bidirectional relationship 104
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C 93
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 92
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 91
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy 59
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 52
Impact of metformin on the incidence of human cholangiocarcinoma in diabetic patients: A systematic review and meta-analysis 48
Functional liver imaging score (FLIS) can predict adverse events in HCC patients 40
Totale 9.114
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.265
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.265
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020206 0 0 0 0 0 0 0 0 0 99 88 19
2020/20211.059 59 53 115 119 89 76 72 98 96 99 76 107
2021/2022771 70 87 87 85 32 57 13 53 37 65 49 136
2022/20231.344 144 446 121 111 82 170 31 82 97 9 38 13
2023/2024856 30 33 22 68 86 262 158 37 61 12 8 79
2024/20251.590 108 210 146 83 172 91 134 71 234 341 0 0
Totale 9.114